Document is current
Any future updates will be listed below
-
Authors
van Eekeren, Louise E.
Vadaq, Nadira
Blaauw, Marc J. T.
Groenendijk, Albert L.
Vos, Wilhelm A. J. W.
Nelwan, Erni J.
Verbon, Annelies
Stalenhoef, Janneke E.
Berrevoets, Marvin A. H.
van Lunzen, Jan
Netea, Mihai G.
Weijers, Gert
Riksen, Niels P.
Rutten, Joost H. W.
de Mast, Quirijn
Tjwa, Eric T. T. L.
Joosten, Leo A. B.
van der Ven, André J. A. M.
-
Funding
Funding for this research was provided by:
ViiV Healthcare (A18-1052, A18-1052, A18-1052, A18-1052)
- License Information
-
More Information
Article History
Received: 4 October 2024
Accepted: 27 January 2025
First Online: 11 February 2025
Declarations
:
: The 2000-HIV study was approved by the Independent Review Board Nijmegen (ref. NL68056.091.81) and the study protocol was published at clinicaltrials.gov (ID: NCT03994835). Written informed consent was obtained from all study participants and experiments were conducted according to the principles of the Declaration of Helsinki.
: Not applicable.
: The authors declare no competing interests.
